R&D

BIO_DRUG PROCESS  
DEVELOPMENT

PIPELINE
ELSA001 Anti-obesity drug (Improved New Drug)
2025.1Q
ELSA002 Anti-obesity drug (Generic)
2024.3Q
ELSA103 Hair loss treatment drug (Long-acting injection)
2026.4Q
ELSA104 Colon cleansing agent
2024.3Q